Arabic Arabic English English French French German German
dark

Oridonin inhibits metastasis of human ovarian cancer cells by suppressing the mTOR pathway.

PMID: 

Arch Med Sci. 2019 Jul ;15(4):1017-1027. Epub 2018 Jul 10. PMID: 31360196

Abstract Title: 

Oridonin inhibits metastasis of human ovarian cancer cells by suppressing the mTOR pathway.

Abstract: 

Introduction: Oridonin, which is isolated from the Chinese herb Rabdosia rubescens, has been reported to exhibit an anti-tumorous effect on different cancers. In this study, we investigated the molecular mechanism by which oridonin suppresses human ovarian cancer.Material and methods: The inhibition of oridonin on cell proliferation was assessed by CCK8 assay. Cell cycle and apoptosis were analyzed by flow cytometry, staining with propidium iodide (PI) or annexin-V/PI respectively. The metastasis rate was evaluated using a transwell migration assay. The expression of metastasis-associated genes and mTOR pathway related genes were detected by western blot.Results: We demonstrated that oridonin suppressed the proliferation and blocked the cell cycle in G1/S phage and induced apoptosis in SKOV3 and A2780 cells (

read more

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Beneficial effects of oridonin on myocardial ischemia/reperfusion injury.

Next Post

Oridonin induces Mdm2-p60 to promote p53-mediated apoptosis and cell cycle arrest in neuroblastoma.

Related Posts
Total
0
Share